Literature DB >> 7875575

A new plasmid (QpDV) common to Coxiella burnetii isolates associated with acute and chronic Q fever.

D Valková1, J Kazár.   

Abstract

Genetic studies of Coxiella burnetii strains suggested the possibility of differentiating new isolates according to their plasmid DNA content. Virulence and/or clinical manifestations ('chronic' and 'acute' Q fever) had been claimed to correlate with this plasmid typing. A new plasmid, named QpDV, was found to be common to C. burnetii isolates obtained from acute and chronic Q fever. According to the results obtained, plasmid usage for detection and differentiation of respective pathovars of C. burnetii and the correlation between gene specificity and pathovar has to be revised. Closer studies suggested a common origin of C. burnetii plasmids, but also showed some differences characteristic for each plasmid, probably reflecting divergent evolution.

Entities:  

Mesh:

Year:  1995        PMID: 7875575     DOI: 10.1111/j.1574-6968.1995.tb07368.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  22 in total

1.  Use of monoclonal antibodies to lipopolysaccharide for antigenic analysis of Coxiella burnetii.

Authors:  Akitoyo Hotta; Midori Kawamura; Ho To; Masako Andoh; Tsuyoshi Yamaguchi; Hideto Fukushi; Ken-Ichi Amano; Katsuya Hirai
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

2.  The Coxiella burnetii cryptic plasmid is enriched in genes encoding type IV secretion system substrates.

Authors:  Daniel E Voth; Paul A Beare; Dale Howe; Uma M Sharma; Georgios Samoilis; Diane C Cockrell; Anders Omsland; Robert A Heinzen
Journal:  J Bacteriol       Date:  2011-01-07       Impact factor: 3.490

3.  Identification and characterization of an immunodominant 28-kilodalton Coxiella burnetii outer membrane protein specific to isolates associated with acute disease.

Authors:  Guoquan Zhang; Ho To; Kasi E Russell; Laura R Hendrix; Tsuyoshi Yamaguchi; Hideto Fukushi; Katsuya Hirai; James E Samuel
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

4.  Comparative genomics reveal extensive transposon-mediated genomic plasticity and diversity among potential effector proteins within the genus Coxiella.

Authors:  Paul A Beare; Nathan Unsworth; Masako Andoh; Daniel E Voth; Anders Omsland; Stacey D Gilk; Kelly P Williams; Bruno W Sobral; John J Kupko; Stephen F Porcella; James E Samuel; Robert A Heinzen
Journal:  Infect Immun       Date:  2008-12-01       Impact factor: 3.441

Review 5.  Diagnosis of Q fever.

Authors:  P E Fournier; T J Marrie; D Raoult
Journal:  J Clin Microbiol       Date:  1998-07       Impact factor: 5.948

6.  Q fever and pregnancy: disease, prevention, and strain specificity.

Authors:  E Angelakis; M Million; F D'Amato; L Rouli; H Richet; A Stein; J-M Rolain; D Raoult
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-09-28       Impact factor: 3.267

Review 7.  From Q Fever to Coxiella burnetii Infection: a Paradigm Change.

Authors:  Carole Eldin; Cléa Mélenotte; Oleg Mediannikov; Eric Ghigo; Matthieu Million; Sophie Edouard; Jean-Louis Mege; Max Maurin; Didier Raoult
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

Review 8.  Coxiella burnetii: international pathogen of mystery.

Authors:  Amanda L Dragan; Daniel E Voth
Journal:  Microbes Infect       Date:  2019-09-28       Impact factor: 2.700

9.  The Coxiella burnetii QpH1 plasmid is a virulence factor for colonizing bone marrow-derived murine macrophages.

Authors:  Shengdong Luo; Shanshan Lu; Huahao Fan; Zhihui Sun; Yan Hu; Ruisheng Li; Xiaoping An; Vladimir N Uversky; Zeliang Chen; Yigang Tong; Lihua Song
Journal:  J Bacteriol       Date:  2021-02-08       Impact factor: 3.490

10.  Genetic diversity of the Q fever agent, Coxiella burnetii, assessed by microarray-based whole-genome comparisons.

Authors:  Paul A Beare; James E Samuel; Dale Howe; Kimmo Virtaneva; Stephen F Porcella; Robert A Heinzen
Journal:  J Bacteriol       Date:  2006-04       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.